Originally posted by dlh Of the three groups most affected by this virus, hydroxychloroquine would be life-saving as to one (young adults) but probably deadly to the other two (small children and old folks). That's because hydroxychloroquine ("Plaquinil") works by suppressing the immune system, which is why it's approved for one autoimmune disorder (rheumatoid arthritis) and currently being tested for use with others (diabetes, Crohns/coeliac/IBS, etc.). The reason it works with folks with strong immune systems is because it can prevent the cytokine release syndrome which is what's actually killing people. That is to say, it's not the virus that's actually killing people, it's their own immune systems' responses to the virus that's killing them. Sort of like what happens to a person with an allergy to peanuts who eats one - the peanut doesn't kill him, it's the immune system response (anaphylactic shock) that kills him. People who contract the infection because they have weak immune systems won't get better by suppressing what little immune system they do have, and could possibly make them worse.
I don't think anyone knows how plaquenil would work against COVID 19, but if it works (I don't think it does), it probably has to do with its ability to block viral replication and prevent the glycosylation of the receptor that the COVID 19 uses to enter cells. The whole immunosuppressant aspect of things is probably a red herring.
But as I said, studies are at best conflicting. The chinese released information showing that in a trial at 7 days there were no differences between hydroxychloroquine and other treatment with regard to viral clearing, but that there was one death in the hydroxychloroquine group versus none in the other.
The reality is that you need a big, double blinded study to really know about this treatment and whether it works (those are going on now in New York). If you have a hundred people with COVID 19 over 70 years old, with the best treatment, your death rate is going to 7 or 8 percent at most. If you take 60 people out of that group and divide them up (as the French study did) in an unblinded fashion and give 15 of them Plaquenil and Zithromax and 15 of them Plaquenil and 30 of them nothing, the end result is at best going to tell you that you need more study. All of the French patients survived. They just said that those on Plaquenil cleared the virus quicker.
This is a nice summary page that summarizes a bit of what we know about chloroquine and hydroxychloroquine.
http://www.familyallergyasthmacare.com/2020/03/is-plaquenil-the-magic-drug-for-covid-19/